SMC Capital China
Unit 2007, Tower 3, No. 69 Lishang Road, Putuo District, Shanghai, 200333, China
Overview
SMC Capital China is an early mover in China private equity, focused on investing in mid-market, growth stage cross border China consumer upgrade plays. Led by Managing Partner Hamilton Tang, our team has strong investment and operations experience from entrepreneurial and multinational corporations operating in China to global investment banks. Our key stakeholders and backers include Simon Murray (former Group Managing Director of Hutchison Whampoa), Thomas Schmidheiny (LafargeHolcim), and China’s Yongjin Group (a leading Chinese direct investment firm). Together with our network of overseas investors, they enable us to provide domestic and cross-border resources to enhance our portfolio's competitiveness and differentiation.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Financial Services
Investment portfolio
- Ryder Horse Industry
Participated · Series B · May 2013
Inner Mongolia Rider Horse Industry, founded in 2006 and led by Chairman and CEO Lang Lin, is the largest non-farming horse breeder and a major horse feedstock trader in China. The company breeds thoroughbred, half-blood, warmblood and Mongolian horses and trades feedstock. Rider is building what it describes as China’s largest horse breeding center to develop higher-quality domestic stock. It also plans to introduce international-quality branded feedstock to the Chinese market and expand into horse club management services. The business has secured growth capital, closing a RMB45 million Series B to support expansion while leveraging a prior Series A from SMC Capital China. Rider benefits from strong support from the Khorchin, Inner Mongolia government and the favorable climate of the Khorchin Prairie.
- Senyint
Led · Series A · Apr 2013
Dalian Senyint International Digital Medical System is a Chinese IT solutions provider for hospitals. The company develops hospital IT solutions and digital medical system products. It received a Series A investment of RMB30 million (approximately US$5 million) from SMC Capital China to further develop its hospital IT solutions products. The funding is intended to support product development and the company’s hospital-facing IT offerings. No revenue, user, or other operating metrics were disclosed in the article. The investor, SMC Capital China, manages both U.S. dollar and local currency funds focused on venture and early growth-stage investments in China.
Team
No current team members are available.